Ceforanide

头孢雷特

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameCeforanide
Drug Alias NameCeforanidum头孢尼特ceforanida头孢拉尼头孢氨甲苯唑 +[8] 
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > β-lactam antibiotics > Cephalosporins antibiotics
Mechanisms of ActionBacterial penicillin-binding protein inhibitorsCell wall inhibitors
TargetsBacterial penicillin-binding protein
Therapy Area/IndicationsEndocarditisPyelonephritisSurgical Wound Infection +[10] 
Global Approved IndicationsSurgical Wound InfectionBacterial Infections
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1984/05/24
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesBristol-Myers Squibb Company
China Registration ClassN/A

Develop Information

Active CompaniesChina Medicine Group General Company Sichuan Bacteriophage Industry Research InstituteJiangsu Sanoya Biomedical Technology Co Ltd
Inactive CompaniesBristol Laboratories Inc
Active IndicationsEndocarditisPyelonephritisUrinary Tract Infections +[8] 
Inactive IndicationsSurgical Wound InfectionBacterial Infections

Other Information

ATC CodeJ01DC11
Related LinksWikipediaDrugBankKEGG